Rime Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Rime Therapeutics General Information

Description

Developer of a peptide-based drug discovery platform designed to identify protein-protein interaction targets and accelerate small molecule development for inflammation and immunology. The company's platform enables the identification of biologically active targets and pharmacologically tractable binding pockets by correlating functional perturbation with pharmacological effect and delivers peptide-based hits with embedded structure-activity relationships, supporting downstream small molecule development, enabling researchers to accelerate the discovery of therapies for inflammation and immunology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3 Place Ville-Marie
  • Suite 12350
  • Montreal, Quebec H3B 0E7
  • Canada
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 3 Place Ville-Marie
  • Suite 12350
  • Montreal, Quebec H3B 0E7
  • Canada

Rime Therapeutics Timeline

2026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rime Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 30-Apr-2026 Completed Startup
2. Accelerator/Incubator 01-Jul-2025 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Rime Therapeutics’s complete valuation and funding history, request access »

Rime Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amplitude Ventures Venture Capital Minority
CQDM Not-For-Profit Venture Capital Minority
Merck Digital Sciences Studio Accelerator/Incubator Minority
PRiME Next-Generation Precision Accelerator/Incubator
To view Rime Therapeutics’s complete investors history, request access »

Rime Therapeutics FAQs

  • When was Rime Therapeutics founded?

    Rime Therapeutics was founded in 2025.

  • Where is Rime Therapeutics headquartered?

    Rime Therapeutics is headquartered in Montreal, Canada.

  • What industry is Rime Therapeutics in?

    Rime Therapeutics’s primary industry is Drug Discovery.

  • Is Rime Therapeutics a private or public company?

    Rime Therapeutics is a Private company.

  • What is Rime Therapeutics’s current revenue?

    The current revenue for Rime Therapeutics is .

  • How much funding has Rime Therapeutics raised over time?

    Rime Therapeutics has raised $100K.

  • Who are Rime Therapeutics’s investors?

    Amplitude Ventures, CQDM, Merck Digital Sciences Studio, and PRiME Next-Generation Precision have invested in Rime Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process